Centessa Pharmaceuticals PLC ADR (CNTA) Insider Trading
- $9,101,824.86
- $20,496,956.62
- July 29, 2025
- Saurabh Saha
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
July 29, 2025 | Insider | 8,322 | $15.23 | Sell | $126,744.06 | |
July 25, 2025 | Insider | 10,000 | $15.56 | Sell | $155,600.00 | |
July 21, 2025 | CEO | 55,000 | $15.92 | Sell | $875,600.00 | |
June 25, 2025 | Insider | 10,000 | $13.86 | Sell | $138,600.00 | |
June 24, 2025 | General Counsel | 12,000 | $14.02 | Sell | $168,240.00 | |
June 24, 2025 | Insider | 15,000 | $14.00 | Sell | $210,000.00 | |
June 20, 2025 | CEO | 55,000 | $12.63 | Sell | $694,650.00 | |
May 27, 2025 | Insider | 10,000 | $12.82 | Sell | $128,200.00 | |
May 20, 2025 | CEO | 55,000 | $12.71 | Sell | $699,050.00 | |
May 16, 2025 | Director | 417,646 | $12.73 | Buy | $5,316,633.58 | |
May 15, 2025 | Director | 44,939 | $12.24 | Buy | $550,053.36 | |
May 1, 2025 | General Counsel | 311 | $14.00 | Sell | $4,354.00 | |
April 28, 2025 | General Counsel | 2,080 | $14.01 | Sell | $29,140.80 | |
April 25, 2025 | Insider | 11,742 | $13.61 | Sell | $159,808.62 | |
April 25, 2025 | General Counsel | 3,609 | $14.00 | Sell | $50,526.00 | |
April 21, 2025 | CEO | 14,656 | $12.29 | Sell | $180,122.24 | |
March 25, 2025 | Insider | 10,000 | $16.34 | Sell | $163,400.00 | |
March 20, 2025 | CEO | 55,000 | $16.69 | Sell | $917,950.00 | |
March 17, 2025 | General Counsel | 6,000 | $16.45 | Sell | $98,700.00 | |
March 17, 2025 | Insider | 7,000 | $17.17 | Sell | $120,190.00 | |
Feb. 20, 2025 | CEO | 55,000 | $15.93 | Sell | $876,150.00 | |
Feb. 18, 2025 | General Counsel | 6,000 | $16.18 | Sell | $97,080.00 | |
Feb. 10, 2025 | Insider | 429 | $18.99 | Sell | $8,146.71 | |
Feb. 7, 2025 | Insider | 30,526 | $19.03 | Sell | $580,909.78 | |
Feb. 3, 2025 | CTO | 11,000 | $16.86 | Sell | $185,460.00 | |
Feb. 3, 2025 | Insider | 6,471 | $16.86 | Sell | $109,101.06 | |
Jan. 27, 2025 | Insider | 11,742 | $16.47 | Sell | $193,390.74 | |
Jan. 21, 2025 | CEO | 55,000 | $15.77 | Sell | $867,350.00 | |
Jan. 15, 2025 | General Counsel | 6,000 | $15.29 | Sell | $91,740.00 | |
Dec. 26, 2024 | Insider | 10,000 | $17.04 | Sell | $170,400.00 | |
Dec. 20, 2024 | CEO | 55,000 | $17.44 | Sell | $959,200.00 | |
Dec. 17, 2024 | CTO | 17,813 | $18.00 | Sell | $320,634.00 | |
Dec. 17, 2024 | Insider | 10,624 | $17.32 | Sell | $184,007.68 | |
Dec. 16, 2024 | General Counsel | 77,705 | $16.39 | Sell | $1,273,584.95 | |
Dec. 13, 2024 | Insider | 5,876 | $17.01 | Sell | $99,950.76 | |
Dec. 6, 2024 | CEO | 87,496 | $18.46 | Sell | $1,615,176.16 | |
Nov. 25, 2024 | CEO | 299 | $18.23 | Sell | $5,450.77 | |
Nov. 25, 2024 | Insider | 10,000 | $17.66 | Sell | $176,600.00 | |
Nov. 22, 2024 | CEO | 1,671 | $18.24 | Sell | $30,479.04 | |
Nov. 20, 2024 | CEO | 55,000 | $16.89 | Sell | $928,950.00 | |
Oct. 25, 2024 | Insider | 11,742 | $15.38 | Sell | $180,591.96 | |
Oct. 23, 2024 | CEO | 2,592 | $15.32 | Sell | $39,709.44 | |
Oct. 21, 2024 | CEO | 22,205 | $15.80 | Sell | $350,839.00 | |
Sept. 25, 2024 | Insider | 16,619 | $15.69 | Sell | $260,752.11 | |
Sept. 20, 2024 | CEO | 55,000 | $16.53 | Sell | $909,150.00 | |
Sept. 10, 2024 | CEO | 175,000 | $16.52 | Sell | $2,891,000.00 | |
Sept. 9, 2024 | Insider | 25,000 | $15.00 | Sell | $375,000.00 | |
Aug. 22, 2024 | CEO | 506 | $12.23 | Sell | $6,188.38 | |
Aug. 22, 2024 | Insider | 12,198 | $12.17 | Sell | $148,449.66 | |
Aug. 20, 2024 | CEO | 4,169 | $12.32 | Sell | $51,362.08 |
Insiders are both buying and selling Centessa Pharmaceuticals PLC ADR stock.
The insider traders at Centessa Pharmaceuticals PLC ADR are: Saurabh Saha, Gregory M Weinhoff, Antoine Yver, Iqbal J Hussain, Karen M Anderson, Tia L Bush, David M Chao, Rubertis Francesco De, Medicxi Ventures Management (J, Harris Rotman, Mario Alberto Accardi, Arjun Goyal, Thomas Templeman, David J Grainger, and Aaron Kantoff
The most active insider trader at Centessa Pharmaceuticals PLC ADR is Saurabh Saha with 21 trades.
Saurabh Saha has sold the most Centessa Pharmaceuticals PLC ADR stock with a total value of $13,773,977.11.
Arjun Goyal has bought the most Centessa Pharmaceuticals PLC ADR stock with a total value of $11,183,320.52.
The most recent insider trade for Centessa Pharmaceuticals PLC ADR was on July 29, 2025.
The single biggest insider buy for Centessa Pharmaceuticals PLC ADR was from Arjun Goyal with a total value of $5,316,633.58 on May 16, 2025.
The single biggest insider sell for Centessa Pharmaceuticals PLC ADR was from Saurabh Saha with a total value of $2,891,000.00 on Sept. 10, 2024.